Alvotech (ALVO) Financials

ALVO Assets vs Liabilities
DateAssetsLiabilities
Dec. 31, 2025 1.5 billion 1.8 billion
Sept. 30, 2025 1.4 billion 1.6 billion
June 30, 2025 1.4 billion 1.6 billion
March 31, 2025 1.2 billion 1.5 billion

ALVO Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
Dec. 31, 2025 -71.5 million 16.1 million
Sept. 30, 2025 -74.5 million -3.4 million
June 30, 2025 42.1 million 2.1 million
March 31, 2025 -10.8 million 1.3 million

ALVO Net Income

No data available :(

ALVO Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
Dec. 31, 2025 172.4 million 1.3 billion 150.1 million
Sept. 30, 2025 42.8 million 1.1 billion 157.8 million
June 30, 2025 151.5 million 1.1 billion 149.9 million
March 31, 2025 38.5 million 1.1 billion 130.2 million

ALVO Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
Dec. 31, 2025 279.2 million
Sept. 30, 2025 300.2 million
June 30, 2025 313.4 million
March 31, 2025 313.4 million

ALVO Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
Dec. 31, 2025 8.6 million 39.7 million 19.6 million -
Sept. 30, 2025 18.9 million 51.6 million 26.0 million -
June 30, 2025 13.6 million 54.7 million 26.7 million -
March 31, 2025 23.4 million 38.2 million 18.6 million -

ALVO Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
Dec. 31, 2025 166.4 million 61.3 million
Sept. 30, 2025 114.0 million 35.0 million
June 30, 2025 173.2 million 73.8 million
March 31, 2025 132.8 million 65.4 million

ALVO

Price: $3.52

52 week price:
2.94
9.94

Earnings Per Share: 0.10 USD

P/E Ratio: 35.50

Exchange: NGM

Sector: Healthcare

Industry: Drug Manufacturers - Specialty & Generic

Market Capitalization: 1.2 billion

Links: